Release Date: 2024-04-04

Newborn Screening for Cystic Fibrosis

Release Date: 2024-04-04

Cystic fibrosis (CF) is a multisystem genetic disease with autosomal recessive inheritance. CF is a progressive and life-shortening disease characterized by recurrent lung infection, exocrine pancreatic insufficiency, malnutrition, growth and developmental delay. Since studies have shown that the course of the disease is better in cases diagnosed in the asymptomatic period, it has been included [...]

Media Type
  • PDF

Buy from

Price may vary by retailers

Work TypeBook Chapter
Published inNewborn and Childhood Screening Programmes
First Page81
Last Page88
DOIhttps://doi.org/10.69860/nobel.9786053358961.6
ISBN978-605-335-896-1 (PDF)
LanguageENG
Page Count8
Copyright HolderNobel Tıp Kitabevleri
Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing
Cystic fibrosis (CF) is a multisystem genetic disease with autosomal recessive inheritance. CF is a progressive and life-shortening disease characterized by recurrent lung infection, exocrine pancreatic insufficiency, malnutrition, growth and developmental delay. Since studies have shown that the course of the disease is better in cases diagnosed in the asymptomatic period, it has been included in newborn screening programs in many countries for early diagnosis. In this article, cystic fibrosis screening programs implemented will be discussed.

Ismail Guzelkas (Author)
Md. Dr., Ankara Yildirim Beyazit University
https://orcid.org/0000-0001-7628-7253
3Ismail Guzelkas works as a pediatric pulmonology specialist. He completed his pediatric pulmonology training at Hacettepe University between 2020-2023. Dr. Guzelkaş has taken part in more than 10 published articles. He currently works at pediatric pulmonology department of Ankara Training and Research Hospital.

  • Refika Ersu, E. Ç., Ayşe Tana Aslan. (2015). Kistik Fibrozis Yenidoğan Tarama Testi ile Tanı Alan Hastaları İzleme Rehberi. TC Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu.

Share This Chapter!